The next era in discovering drugs in nature's own medicine cabinet

Sep 04, 2013

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Lisa M. Jarvis, C&EN senior editor, points out that natural products are the source of about half of the modern drugs approved in the U.S. But the search for new products slowed as drug companies learned to make synthetic compounds at high speeds by the thousands. Now, the increasing availability and affordability of DNA sequencing is reviving activity in the field. It enables scientists to sample the DNA of thousands of microbes at once in search of gene clusters that could yield a new drug. Then computer models can figure out what molecules the genes encode, and organize the information in searchable databases.

The potential for discovering new medicines is high enough to attract the attention—and millions of dollars in investments—of some of the pharmaceutical industry's major players, including Sanofi and Novartis. The article notes that the latest research has significantly increased the number of microbial compounds being discovered and has opened a window on a vast new library of genes and gene clusters that code for previously undiscovered drugs. The flood of genetic discovery underpins expectations that potential new medicines based on natural products will be in clinical trials in humans within a few years.

Explore further: Jumping hurdles in the RNA world

More information: "Nature's Second Act" cen.acs.org/articles/91/i35/Na… ures-Second-Act.html

add to favorites email to friend print save as pdf

Related Stories

Chemical company giants stall with global economy

Jul 31, 2013

The world's 50 largest chemical companies—with combined 2012 sales of almost $1 trillion and products that touch the lives of people everywhere—are the topic of the cover story in the current edition of Chemical & En ...

Microdosing: Updating its role in developing new medicines

Jan 23, 2013

One of yesterday's most promising new tools for speeding the development of new medicines—"microdosing"—has found niches in that process today, and they include uses unanticipated a decade ago. That topic, an update on ...

Renewed hope in a once-abandoned cancer drug class

Jun 19, 2013

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

Preventing cancer, quite naturally

Jun 23, 2010

Exciting headlines about the cancer-preventing potential of berries, red wine, and other foods are in the news almost every day. An article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, ...

Recommended for you

Molecules that came in handy for first life on Earth

25 minutes ago

For the first time, chemists have successfully produced amino acid-like molecules that all have the same 'handedness', from simple building blocks and in a single test tube. Could this be how life started. ...

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.